Zhi-Bin Yan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhi-Bin Yan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Caiyun Fu
Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, Zhejiang Provincial Key Laboratory of Drug Discovery and Development for Metabolic Diseases, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China
1 shared publication - Gang Shao
Department of Oncology, No.903 Hospital of PLA Joint Logistic Support Force, Hangzhou 310013, China
1 shared publication - Jian Kang
St. Vincent’s Institute of Medical Research, Melbourne, VIC 3065, Australia
1 shared publication - Juan Jin
Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech University, Hangzhou, China
1 shared publication - Jun Liu
Department of Chemistry and Biochemistry University of Delaware Newark DE 19716 USA
1 shared publication - Jun-Jie Ma
Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China
1 shared publication
Latest Publications
- Open Access
- 2 July 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (13) , 7268
The Role of Lutheran/Basal Cell Adhesion Molecule in Hematological Diseases and Tumors
Cell adhesion is a dynamic process that plays a fundamental role in cell proliferation, maintenance, differentiation, and migration. Basal cell adhesion molecule (BCAM), also known as Lutheran (Lu), belongs to the immunoglobulin superfamily of cell adhesion molecules. Lu/BCAM, which is widely expressed in red blood cells, endothelial cells, smooth muscle cells and epithelial cells across various tissues, playing a crucial role in many cellular processes, including cell adhesion, cell motility and cell migration. Moreover, Lu/BCAM, dysregulated in many diseases, such as blood diseases and various types of cancer, may act as a biomarker and target for the treatment of these diseases. This review explores the significance of Lu/BCAM in cell adhesion and its potential as a novel target for treating hematological diseases and tumors.
- 2 July 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (13) , 7268
Open AccessThe Role of Lutheran/Basal Cell Adhesion Molecule in Hematological Diseases and Tumors
Cell adhesion is a dynamic process that plays a fundamental role in cell proliferation, maintenance, differentiation, and migration. Basal cell adhesion molecule (BCAM), also known as Lutheran (Lu), belongs to the immunoglobulin superfamily of cell adhesion molecules. Lu/BCAM, which is widely expressed in red blood cells, endothelial cells, smooth muscle cells and epithelial cells across various tissues, playing a crucial role in many cellular processes, including cell adhesion, cell motility and cell migration. Moreover, Lu/BCAM, dysregulated in many diseases, such as blood diseases and various types of cancer, may act as a biomarker and target for the treatment of these diseases. This review explores the significance of Lu/BCAM in cell adhesion and its potential as a novel target for treating hematological diseases and tumors.
- Top Cited PapersOpen Access
- 9 September 2021
- Published by Elsevier in Military Medical Research
- Vol. 8 (1) , 1-25
Antimicrobial peptides: mechanism of action, activity and clinical potential
- 9 September 2021
- Published by Elsevier in Military Medical Research
- Vol. 8 (1) , 1-25
Top Cited PapersOpen AccessAntimicrobial peptides: mechanism of action, activity and clinical potential